United States · FDA National Drug Code directory
daptomycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71839-107_41e692d7-587f-a852-e063-6294a90aded1
- Product NDC
- 71839-107
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- daptomycin
- Labeler
- BE Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190626
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPTOMYCIN — 500 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (71839-107-01) / 10 mL in 1 VIAL, SINGLE-DOSE · 71839-107-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →